IL1B and gastroenteritis: Contrary to the anti-inflammatory cytokines, IL-1β, IL-6, and TNF-α, as pro-inflammatory cytokines which have been reported in the intestinal inflammation occurrence (Singh et al., 2020; Kim et al., 2021), were dose-dependently decreased by SSPs administration.